Prevalence of IR % (n) | |
Whole Population | 79.1 (129) |
ATP III-MetS | 88.7 (55/62) |
IDF-MetS | 79.3 (46/58) |
SSA-MetS | 84.6 (11/13) |
ATP III-AO | 71.4 (60/84) |
IDF-AO | 75.5 (102/135) |
SSA-AO | 91.1 (113/124) |
Diabetic patients | 60.3 (35/58) |
Non-diabetic and non-obese patients | 44.8 (47/105) |